Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
8.21
-0.07 (-0.85%)
Nov 4, 2024, 4:00 PM EST - Market closed
Theravance Biopharma Employees
Theravance Biopharma had 99 employees as of December 31, 2023. The number of employees decreased by 12 or -10.81% compared to the previous year.
Employees
99
Change (1Y)
-12
Growth (1Y)
-10.81%
Revenue / Employee
$626,434
Profits / Employee
-$461,141
Market Cap
401.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
Ginkgo Bioworks Holdings | 1,218 |
Organogenesis Holdings | 862 |
REGENXBIO | 344 |
Esperion Therapeutics | 240 |
Akebia Therapeutics | 167 |
4D Molecular Therapeutics | 147 |
MaxCyte | 143 |
TBPH News
- 12 days ago - Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 - PRNewsWire
- 17 days ago - Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease - PRNewsWire
- 2 months ago - Theravance Biopharma to Participate in an Upcoming Investor Conference - PRNewsWire
- 3 months ago - Theravance Biopharma, Inc. (TBPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 3 months ago - Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 - PRNewsWire
- 6 months ago - Theravance Biopharma, Inc. (TBPH) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update - PRNewsWire